Post by account_disabled on Jan 9, 2024 15:38:01 GMT 10
Making Science , a technology and digital marketing consultancy specializing in e-commerce and digital transformation, has presented its financial results for the third quarter of 2020. The amount of the Turnover in the third quarter of the year stands at 13,942,000 euros . During the third quarter of 2020, the Making Science business has continued to grow, following the trend of recent years. Thus, the amount of EBITDA, with 871 thousand euros, has represented a growth of 1.2% compared to the second quarter of the year and represents 24.3% of the accumulated Gross Margin as of September 2020 , 4.3 points higher than 2019 equivalent.
The catalytic effects of the digitalization that the pandemic has had, the consolidation of the business Email Data in Spain with strategic acquisitions such as Cloudforms, and the advancement of the internationalization process with the recent acquisition of Omniaweb , place the company closer to its objective of Expand to 20 markets in the next 5 years. In the words of José Antonio Martínez Aguilar, CEO of Making Science : “ Although we remain cautious in our estimates, EBITDA levels have increased slightly compared to the previous two quarters and we expect to end the year with a pro forma consolidated EBITDA of 4.7 million of euros with a growth of 88% year over year.
We are confident in the solidity of our project in a winning sector that offers us great development potential as a company .” The company has scheduled a presentation of results through a webinar where its CEO will share its results, as well as the interim Financial Statements for the first half of 2020 , and the corporate operations that have been carried out during 2020. This webinar will be open to everyone those investors, analysts and interested people, who will be able to follow the presentation online and ask any questions they consider appropriate. Boosting growth strategy in the third quarter Making Science announced last July the acquisition of the company Cloudform as part of its growth strategy. With this move, the company continues to implement its strategic plan to, in the medium term, become one of the leading players that accompanies the market in the growth of the entire Salesforce suite .
The catalytic effects of the digitalization that the pandemic has had, the consolidation of the business Email Data in Spain with strategic acquisitions such as Cloudforms, and the advancement of the internationalization process with the recent acquisition of Omniaweb , place the company closer to its objective of Expand to 20 markets in the next 5 years. In the words of José Antonio Martínez Aguilar, CEO of Making Science : “ Although we remain cautious in our estimates, EBITDA levels have increased slightly compared to the previous two quarters and we expect to end the year with a pro forma consolidated EBITDA of 4.7 million of euros with a growth of 88% year over year.
We are confident in the solidity of our project in a winning sector that offers us great development potential as a company .” The company has scheduled a presentation of results through a webinar where its CEO will share its results, as well as the interim Financial Statements for the first half of 2020 , and the corporate operations that have been carried out during 2020. This webinar will be open to everyone those investors, analysts and interested people, who will be able to follow the presentation online and ask any questions they consider appropriate. Boosting growth strategy in the third quarter Making Science announced last July the acquisition of the company Cloudform as part of its growth strategy. With this move, the company continues to implement its strategic plan to, in the medium term, become one of the leading players that accompanies the market in the growth of the entire Salesforce suite .